Endace and Artiza Networks Partner to Deliver Cybersecurity and Defense Solutions to the Japanese Market
8.7.2026 13:00:00 CEST | Business Wire | Press Release
Endace, a leading provider of always-on packet capture, network visibility, and packet forensics solutions, and Artiza Networks, Inc. ("Artiza"), a leading provider of telecommunications test, measurement, and network assurance solutions, today announced a partnership to deliver advanced cybersecurity and defense solutions to customers in Japan.
“Artiza is exactly the partner we have been looking for to satisfy demand in Japan, with the right balance of expertise, and market reach,” said Stuart Wilson, CEO of Endace.
Through this partnership, Artiza will offer Endace's packet capture, network recording, and packet forensics solutions to customers in Japan, including telecommunications operators, enterprises, government agencies, defense organizations, and critical infrastructure providers.
Endace's EndaceProbe Analytics Platform provides highly scalable, always-on packet capture and recording capabilities across a wide range of network environments, including enterprise networks, data centers, telecommunications networks, on-premises infrastructures, hybrid cloud environments, and public cloud deployments. The platform enables Security Operations Center (SOC) and Network Operations Center (NOC) teams to investigate cybersecurity incidents, network performance issues, and operational anomalies by providing access to complete packet-level evidence.
Endace solutions integrate with a broad range of cybersecurity and network monitoring platforms, providing direct access to definitive packet evidence required for incident investigation, threat hunting, and root-cause analysis.
By making complete packet-level evidence available to security and operations teams, Endace helps organizations improve the effectiveness of cybersecurity investigations and network performance analysis.
In addition, Endace solutions have achieved important security certifications and approvals, including NIST FIPS 140-3 validation, Common Criteria / NIAP certification, and inclusion on the U.S. Department of Defense Information Network Approved Products List (DoDIN APL). These achievements demonstrate compliance with some of the world's most demanding cybersecurity requirements for government, defense, and critical infrastructure environments.
By combining Endace's advanced packet visibility and packet forensics technologies with Artiza's strong presence in the Japanese telecommunications and technology markets, the two companies will work together to support organizations seeking enhanced cybersecurity, operational resilience, and network assurance capabilities.
About Endace
Endace’s scalable, always-on packet capture gives Network Operations and Security teams the deep visibility they need for fast, accurate incident investigation with rich forensic evidence at their fingertips from all their tools. EndaceProbes provide enterprise-class packet sniffing in on-prem, public and private cloud environments, with rapid, centralized search and one-click access to full pcap data from leading security and performance solutions (including Microsoft, Palo Alto Networks, Fortinet, Cisco, Splunk, Elastic, and many others). Analyze network traffic using a single, unified console across all on-prem, private, or public cloud infrastructure for total hybrid cloud visibility. Capture every packet. See every threat. www.endace.com
About Artiza Networks
Artiza Networks is the leader in radio access network (RAN) and core network (CN) testing for 3G, 4G, and 5G. For over 30 years, Artiza has collaborated with the industry's top vendors and operators in testing the RAN and core network nodes of the world's most advanced cellular networks. With extensive engineering resources including PCB and FPGA/DSP development, award-winning customer support, and a sales force versed in mobile network technology, Artiza meets the full range of customer needs through innovative, in-house development of products and solutions.
Artiza Networks, Inc. (TSE 6778)
Established: 27 December 1990
www.artizanetworks.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260708462599/en/
Contacts
For more information, contact:
Endace
Email: pr@endace.com
Phone:
Mark Evans, mobile +64-21-494 850 – New Zealand / APAC
Kimber Smith-Fidler, mobile +1 775 298 5260 – USA / North America
Leah Jones (The CommsCo), mobile +44 203 697 6680 – UK / EMEA
Artiza Networks
Network Product Business Operations
+81-42-529-3494
Contact: https://www.artizanetworks.com/contact.html#contactForm -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.artizanetw
orks.com%2Fcontact.html%23contactForm&esheet=54566111&newsitemid=20260708462599&
lan=en-US&anchor=https%3A%2F%2Fwww.artizanetworks.com%2Fcontact.html%23contactFo
rm&index=5&md5=8c4ea1dbb727fb3caf2797f5967b2ac2
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press Release
Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and smaller, regional community-based networks alike. The financing will scale manufacturing and accelerate commercial deployment, and continue clinical and product development across Leo Cancer Care’s integrated u
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press Release
The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer of its kind, combining quantum error correction with NISQ qubits. The system will be delivered in 2027, followed by a series of upgrades delivered in multiple phases with an increasing number of logical qubits. The IQM Halocene H4 and the upgraded systems will enable LUMI consortium users, for the first time, to develop and implement Quantum Error Correction (QEC) concepts on a world-leadi
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press Release
Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manifestations, often associated with substantial physical and psychosocial burden, the lack of targeted treatment makes the disease hard to control,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “This Breakthrough Therapy designation demonstrates that enpatoran has the potential to redefine how we approach lupus, by addressing the visible burden of rash, while potentially driving benefit beyond the skin. We look forward to working with the FDA to potentially bring this much-needed option to
Fastly Joins DIMPACT to Collaborate on Digital Sustainability8.7.2026 14:00:00 CEST | Press Release
Fastly, Inc. (NASDAQ: FSLY), a leading global edge cloud platform, today announced it has become a participant of DIMPACT, the coalition of leading organizations working to align industry changemakers and policymakers around meaningful, science-based solutions that reduce the environmental impacts of serving digital media products. As the first edge cloud platform provider to join the coalition, Fastly brings critical, real-world edge network data and infrastructure expertise and a transparent approach to emissions calculation and reporting to help major media, streaming, and publishing companies understand and optimize their digital carbon footprints. “We’re thrilled to welcome Fastly to the DIMPACT initiative. Their participation strengthens DIMPACT's ability to advance a more accurate, data-driven approach to measuring and reducing digital emissions,” said Jason Bell, Director at SLR Consulting and Executive Sponsor of DIMPACT. “Accurately calculating digital emissions requires a de
PubNub Introduces Blocks.ai: The Control Plane and Network Layer For AI Agents8.7.2026 14:00:00 CEST | Press Release
PubNub introduces Blocks.ai today, a global network to connect and control agents across all agent frameworks, providers, and APIs. Blocks.ai lets developers reach their existing AI agents regardless of where they are hosted. Blocks Network supports all AI agent use cases without opening inbound ports, setting up tunnels, changing DNS, or modifying firewall rules. For more than a decade, PubNub has been the infrastructure and platform for real-time connectivity supporting billions of devices, now, PubNub delivers Blocks Network connecting the Internet of Agents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708521206/en/ AI agents have become increasingly critical to businesses who want control over their models, code, and data. But once those agents are running locally or behind a firewall, making them reachable from custom frontends can require brittle infrastructure work. This is a key reason why McKinsey estimates th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom